BMJ Open (Jun 2023)

Child Developmental MRI (CDM) project: protocol for a multi-centre, cross-sectional study on elucidating the pathophysiology of attention-deficit/hyperactivity disorder and autism spectrum disorder through a multi-dimensional approach

  • Tsuyoshi Sasaki,
  • Tetsuya Tsujikawa,
  • Hidehiko Okazawa,
  • Sayo Hamatani,
  • Yoshiyuki Hirano,
  • Eiji Shimizu,
  • Akemi Tomoda,
  • Koji Matsumoto,
  • Masatoshi Yamashita,
  • Yoshifumi Mizuno,
  • Kuriko Kagitani-Shimono,
  • Shota Nishitani,
  • Akiko Yao,
  • Sawa Kurata,
  • Hirotaka Kosaka,
  • Minyoung Jung,
  • Tokiko Yoshida,
  • Yoko Kato,
  • Mariko Nakanishi,
  • Masaya Tachibana,
  • Ikuko Mohri,
  • Kenji J Tsuchiya,
  • Masako Taniike

DOI
https://doi.org/10.1136/bmjopen-2022-070157
Journal volume & issue
Vol. 13, no. 6

Abstract

Read online

Introduction Neuroimaging studies on attention-deficit/hyperactivity disorder (ADHD) and autism spectrum disorder (ASD) have demonstrated differences in extensive brain structure, activity and network. However, there remains heterogeneity and inconsistency across these findings, presumably because of the diversity of the disorders themselves, small sample sizes, and site and parameter differences in MRI scanners, and their overall pathogenesis remains unclear. To address these gaps in the literature, we will apply the travelling-subject approach to correct site differences in MRI scanners and clarify brain structure and network characteristics of children with ADHD and ASD using large samples collected in a multi-centre collaboration. In addition, we will investigate the relationship between these characteristics and genetic, epigenetic, biochemical markers, and behavioural and psychological measures.Methods and analysis We will collect resting-state functional MRI (fMRI) and T1-weighted and diffusion-weighted MRI data from 15 healthy adults as travelling subjects and 300 children (ADHD, n=100; ASD, n=100; and typical development, n=100) with multi-dimensional assessments. We will also apply data from more than 1000 samples acquired in our previous neuroimaging studies on ADHD and ASD.Ethics and dissemination The study protocol has been approved by the Research Ethics Committee of the University of Fukui Hospital (approval no: 20220601). Our study findings will be submitted to scientific peer-reviewed journals and conferences.